Med (Med)

Med is a flagship medical journal published monthly by Cell Press, the global publisher of trusted and authoritative science journals including Cell, Cancer Cell, and Cell Reports Medicine. Our mission is to advance clinical research and practice by providing a communication forum for the publication of clinical trial results, innovative observations from longitudinal cohorts, and pioneering discoveries about disease mechanisms. The journal also encourages thought-leadership discussions among biomedical researchers, physicians, and other health scientists and stakeholders. Our goal is to improve health worldwide sustainably and ethically. Med publishes rigorously vetted original research and cutting-edge review and perspective articles on critical health issues globally and regionally. Our research section covers clinical case reports, first-in-human studies, large-scale clinical trials, population-based studies, as well as translational research work with the potential to change the course of medical research and improve clinical practice. We are interested in research with immediate impact on clinical practice and health policy. These can be pre-defined outcomes from clinical trials, epidemiology studies from established cohorts, meta-analyses of clinical observations and trials, as well as translational research papers reporting substantial knowledge breakthroughs in disease mechanisms or technological advances with clear clinical impact.

Med (Med) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer, Cardiovascular, metabolic diseases, Digital health, Healthy aging, Cancer Cell , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2666-6359, E-ISSN: 2666-6340, Established: 2020,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE